← Leaderboards

Richard T D'aquila

Massachusetts General Hospital

Google Scholar ↗PubMed ↗ORCID ↗

$62,924,506

Attributed

$75,905,823

Total exposure

19

Grants

15

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $20.4M · FY2005–25

$25M$18.8M$12.5M$6.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$126,721,400 · 22

By mechanism

P30$54,503,915 · 10

UL1$27,454,413 · 1

UM1$15,503,048 · 1

P01$11,266,865 · 3

U01$8,801,204 · 1

R01$7,361,334 · 3

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Steven A Safren$27,216,676
Yee-Ming Chan$5,143,430
Zhongcong Xie$19,705,169
George J Hanna$206,861
Conall Michael O'Cleirigh$14,994,576

Others in their field

Top investigators on “Innovation”

David R. Weir · University Of Michigan At Ann Arbor$382,307,654
Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
Richard A Gibbs · Baylor College Of Medicine$300,634,418
Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
Judith S. Currier · University Of California Los Angeles$271,752,220

Research focus

InnovationCollaborationsResearch PersonnelProgramsChicagoCommunitiesBaseFundingDesignInstitutionAcquired Immunodeficiency SyndromePublic HealthCaringResourcesUniversitiesTranslational ResearchWorking GroupStrategic PlanningProductivityEpidemicClinical SciencesInfrastructureReportingMentors

Grant awards (106)

NUCATS CTSA UM1 at Northwestern University$7,541,744

UM1 · FY2025 · TR · contact PI

Third Coast Center for AIDS Research$2,498,643

P30 · FY2025 · AI

NUCATS CTSA UM1 at Northwestern University$7,961,304

UM1 · FY2024 · TR · contact PI

Third Coast Center For AIDS Research$1,364,656

P30 · FY2024 · AI

Third Coast Center for AIDS Research$1,200,000

P30 · FY2024 · AI

Third Coast Center For AIDS Research$232,717

P30 · FY2024 · AI

Third Coast Center For AIDS Research$209,571

P30 · FY2024 · AI

Third Coast Center For AIDS Research$204,816

P30 · FY2024 · AI

Northwestern University Clinical and Translational Science Institute (NUCATS)$3,968,263

UL1 · FY2023 · TR · contact PI

Third Coast Center For AIDS Research$1,576,513

P30 · FY2023 · AI

Third Coast Center For AIDS Research$1,064,754

P30 · FY2023 · AI

Third Coast Center For AIDS Research$240,002

P30 · FY2023 · AI

Third Coast Center For AIDS Research$236,183

P30 · FY2023 · AI

Third Coast Center For AIDS Research$230,593

P30 · FY2023 · AI

Northwestern University Clinical and Translational Science Institute (NUCATS)$7,269,909

UL1 · FY2022 · TR · contact PI

Third Coast Center For AIDS Research$4,716,604

P30 · FY2022 · AI

Next-Generation Phylodynamics-targeted Partner Service Models for Combined HIV Prevention$786,169

R01 · FY2022 · AI

Northwestern University Clinical and Translational Science Institute (NUCATS)$7,327,689

UL1 · FY2021 · TR · contact PI

Third Coast Center For AIDS Research$5,048,227

P30 · FY2021 · AI · contact PI

Developmental Core$4,115,910

P30 · FY2021 · AI · contact PI

Pathogenesis of Rebound SIV/HIV Viremia after Antiretrovral Therapy$1,511,798

P01 · FY2021 · AI · contact PI

Next-Generation Phylodynamics-targeted Partner Service Models for Combined HIV Prevention$786,493

R01 · FY2021 · AI

Cellular Metabolic Reprogramming and Virus Infectivity$604,837

P01 · FY2021 · AI · contact PI

Administrative Core$480,894

P30 · FY2021 · AI · contact PI

Northwestern University Clinical and Translational Science Institute (NUCATS)$225,973

UL1 · FY2021 · TR · contact PI

Northwestern University Clinical and Translational Science Institute (NUCATS)$208,475

UL1 · FY2021 · TR · contact PI

Pathogenesis of Rebound SIV/HIV Viremia After Antiretroviral Therapy$59,263

P01 · FY2021 · AI · contact PI

Northwestern University Clinical and Translational Science Institute (NUCATS)$7,170,855

UL1 · FY2020 · TR · contact PI

Third Coast Center For AIDS Research$3,488,048

P30 · FY2020 · AI · contact PI

Developmental Core$1,529,875

P30 · FY2020 · AI · contact PI

Pathogenesis of Rebound SIV/HIV Viremia after Antiretrovral Therapy$1,527,040

P01 · FY2020 · AI · contact PI

Administrative Core$1,243,386

P30 · FY2020 · AI · contact PI

Next-Generation Phylodynamics-targeted Partner Service Models for Combined HIV Prevention$788,275

R01 · FY2020 · AI

Northwestern University Clinical and Translational Science Institute (NUCATS)$678,232

UL1 · FY2020 · TR · contact PI

Cellular Metabolic Reprogramming and Virus Infectivity$559,940

P01 · FY2020 · AI · contact PI

Northwestern University Clinical and Translational Science Institute (NUCATS)$226,346

UL1 · FY2020 · TR · contact PI

Northwestern University Clinical and Translational Science Institute (NUCATS)$208,379

UL1 · FY2020 · TR · contact PI

Northwestern University Clinical and Translational Science Institute (NUCATS)$170,292

UL1 · FY2020 · TR · contact PI

Pathogenesis of Rebound SIV/HIV Viremia After Antiretroviral Therapy$60,340

P01 · FY2020 · AI · contact PI

Third Coast Center for AIDS Research$2,697,308

P30 · FY2019 · AI · contact PI

Pathogenesis of Rebound SIV/HIV Viremia after Antiretrovral Therapy$1,525,830

P01 · FY2019 · AI · contact PI

Core A: Administrative Core$1,145,324

P30 · FY2019 · AI · contact PI

Next-Generation Phylodynamics-targeted Partner Service Models for Combined HIV Prevention$790,057

R01 · FY2019 · AI

Cellular Metabolic Reprogramming and Virus Infectivity$518,531

P01 · FY2019 · AI · contact PI

Pathogenesis of Rebound SIV/HIV Viremia after Antiretrovral Therapy$153,500

P01 · FY2019 · AI · contact PI

Cellular Metabolic Reprogramming and Virus Infectivity$153,500

P01 · FY2019 · AI · contact PI

Pathogenesis of Rebound SIV/HIV Viremia After Antiretroviral Therapy$92,678

P01 · FY2019 · AI · contact PI

Third Coast Center for AIDS Research$2,189,210

P30 · FY2018 · AI · contact PI

Pathogenesis of Rebound SIV/HIV Viremia after Antiretrovral Therapy$1,633,176

P01 · FY2018 · AI · contact PI

Next-Generation Phylodynamics-targeted Partner Service Models for Combined HIV Prevention$817,933

R01 · FY2018 · AI

Cellular Metabolic Reprogramming and Virus Infectivity$516,794

P01 · FY2018 · AI · contact PI

Core A: Administrative Core$452,981

P30 · FY2018 · AI · contact PI

Pathogenesis of Rebound SIV/HIV Viremia After Antiretroviral Therapy$104,452

P01 · FY2018 · AI · contact PI

Third Coast Center for AIDS Research$2,177,081

P30 · FY2017 · AI · contact PI

Pathogenesis of Rebound SIV/HIV Viremia after Antiretrovral Therapy$1,602,839

P01 · FY2017 · AI · contact PI

Core A: Administrative Core$668,694

P30 · FY2017 · AI · contact PI

Cellular Metabolic Reprogramming and Virus Infectivity$536,099

P01 · FY2017 · AI · contact PI

Pathogenesis of Rebound SIV/HIV Viremia After Antiretroviral Therapy$106,248

P01 · FY2017 · AI · contact PI

Third Coast Center for AIDS Research$1,974,259

P30 · FY2016 · AI · contact PI

Core A: Administrative Core$725,392

P30 · FY2016 · AI · contact PI

Third Coast Center for AIDS Research$1,810,226

P30 · FY2015 · AI · contact PI

Core A: Administrative Core$595,002

P30 · FY2015 · AI · contact PI

Vanderbilt HIV Clinical Trials Unit$1,588,407

U01 · FY2011 · AI · contact PI

Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program$233,075

T32 · FY2011 · AI · contact PI

Administrative Core$98,651

P30 · FY2011 · AI · contact PI

Developmental Core$68,688

P30 · FY2011 · AI · contact PI

Vanderbilt HIV Clinical Trials Unit$1,562,084

U01 · FY2010 · AI · contact PI

Vanderbilt Meharry Center for AIDS Research$1,302,486

P30 · FY2010 · AI · contact PI

Vanderbilt Meharry Center for AIDS Research$364,297

P30 · FY2010 · AI · contact PI

Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program$193,039

T32 · FY2010 · AI · contact PI

Vanderbilt HIV Clinical Trials Unit$2,006,746

U01 · FY2009 · AI · contact PI

Vanderbilt Meharry Center for AIDS Research$1,718,609

P30 · FY2009 · AI · contact PI

Molecular Basis of Infectious Diseases Training Program$192,400

T32 · FY2009 · AI · contact PI

Vanderbilt HIV Clinical Trials Unit$1,989,708

U01 · FY2008 · AI · contact PI

Vanderbilt Meharry Center for AIDS Research$1,239,754

P30 · FY2008 · AI · contact PI

Molecular Basis of Infectious Diseases Training Program$269,835

T32 · FY2008 · AI · contact PI

Seed Grant Program in AIDS Malignancy Research$250,000

P30 · FY2008 · AI · contact PI

Vanderbilt Meharry Center for AIDS Research$250,000

P30 · FY2008 · AI · contact PI

Vanderbilt HIV Clinical Trials Unit$1,654,259

U01 · FY2007 · AI · contact PI

Vanderbilt Meharry Center for AIDS Research$1,197,225

P30 · FY2007 · AI · contact PI

HIV Resistance and Treatment Strategies$357,938

R01 · FY2007 · AI · contact PI

Molecular Basis of Infectious Diseases Training Program$264,253

T32 · FY2007 · AI · contact PI

Vanderbilt Meharry Center for AIDS Research$1,339,006

P30 · FY2006 · AI · contact PI

HIV Resistance and Treatment Strategies$368,629

R01 · FY2006 · AI · contact PI

Molecular Basis of Infectious Diseases Training Program$315,393

T32 · FY2006 · AI · contact PI

ADMINISTRATIVE CORE$267,724

P30 · FY2006 · AI · contact PI

BLOOD MONONUCLEAR CELLS COLLECTION FROM HEALTHY DONORS$14,262

M01 · FY2006 · RR · contact PI

Vanderbilt Meharry Developmental CFAR$781,241

P30 · FY2005 · AI

HIV Resistance and Treatment Strategies$377,500

R01 · FY2005 · AI

Molecular Basis of Infectious Diseases Training Program$315,393

T32 · FY2005 · AI

BLOOD MONONUCLEAR CELLS COLLECTION FROM HEALTHY DONORS$11,513

M01 · FY2005 · RR

Vanderbilt Meharry Developmental CFAR$759,365

P30 · FY2004 · AI

HIV Resistance and Treatment Strategies$339,750

R01 · FY2004 · AI

BLOOD MONONUCLEAR CELLS COLLECTION FROM HEALTHY DONORS$21,458

M01 · FY2004 · RR

Vanderbilt Meharry Developmental CFAR$750,000

P30 · FY2003 · AI

HIV RESISTANCE AND TREATMENT STRATEGIES$322,663

R01 · FY2003 · AI

HIV RESISTANCE AND TREATMENT STRATEGIES$331,430

R01 · FY2002 · AI

Core--Virology$0

P30 · FY2002 · AI

Core--Virology$0

P30 · FY2002 · AI

HIV RESISTANCE AND TREATMENT STRATEGIES$322,663

R01 · FY2001 · AI

DRUG RESISTANT HIV1 IN SEMEN$243,207

R01 · FY2001 · AI

DRUG RESISTANT HIV1 IN SEMEN$69,468

R01 · FY2001 · AI

Core--Virology$0

P30 · FY2001 · AI

HIV RESISTANCE AND TREATMENT STRATEGIES$353,778

R01 · FY2000 · AI

DRUG RESISTANT HIV1 IN SEMEN$305,381

R01 · FY2000 · AI

Core--Virology$0

P30 · FY2000 · AI